or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    ELMD A Electromed, Inc. 6.13
    BMY B Bristol-Myers Squibb Company 1.10
    PTCT B PTC Therapeutics, Inc. 0.79
    TRDA B Entrada Therapeutics, Inc. 4.16
    TVTX B Travere Therapeutics, Inc. -0.05
    BNTC C Benitec Biopharma Limited 2.84
    WVE C WAVE Life Sciences Ltd. -0.56
    SMMT D Summit Therapeutics plc 3.15
    SRPT D Sarepta Therapeutics, Inc. 3.38
    SLDB F Solid Biosciences Inc. 3.44
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Muscular Dystrophy Biopharmaceutical Duchenne Muscular Dystrophy Duchenne Biotechnology Medicine Biology Disease Genetic Genealogy Medical Genetics Clinic Cystic Fibrosis Cytoskeleton Dystrophin Gene Expression Hepatitis B Hepatitis C Huntington's Disease Infectious Diseases Life Sciences

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 9.3
    MEDX F Horizon Kinetics Medical ETF 9.09
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL A SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    RDIV A RevenueShares Ultra Dividend Fund 5.27
    View all Dystrophy ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to RDIV Compare PPH to MVAL

        Dystrophy Stocks Recent News

        Date Stock Title
        Nov 22 SRPT High Growth Tech Stocks to Watch in November 2024
        Nov 22 BMY AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 21 BMY Major companies that are also popular short-selling stocks
        Nov 21 BMY Is Bristol Myers Squibb Stock a Buy?
        Nov 21 BMY Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
        Nov 20 SMMT Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why
        Nov 19 BMY Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
        Nov 19 BMY Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
        Nov 18 BMY Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
        Nov 18 BMY Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
        Nov 18 BMY EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
        Nov 17 BMY Bristol-Myers Squibb: Buy This Bargain Before It's Gone
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Muscular Dystrophy Biopharmaceutical Disease Medicine Biotechnology Duchenne Duchenne Muscular Dystrophy Hepatitis B Hepatitis C Biology Cancer Clinic Cystic Fibrosis Diabetes Disorders Drug Discovery Dystrophin Facioscapulohumeral Muscular Dystrophy Gene Expression Genetic Genealogy
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags